Clinical trial

Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma

NCT06983704

Study summary

ClinicalTrials.gov

Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention AGV plate Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention bevacizumab injection Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-02-09

PhaseEARLY_PHASE1

Conditions

Pediatric Glaucomaunresolved

Interventions

AGV platePROCEDURE

bevacizumab injectionPROCEDURE

Sponsors & collaborators

Benha Universitylead sponsor

Mapped research locations

CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06983704 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.